Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update
作者： Jessica P. Hwang , Mark R. Somerfield , Devena E. Alston-Johnson , Donna R. Cryer , Jordan J. Feld
关键词: HBsAg 、 Hematopoietic stem cell transplantation 、 Transplantation 、 Mass screening 、 Internal medicine 、 Medicine 、 Hepatitis B 、 Cancer 、 Hepatitis B virus 、 Context (language use) 、 Surgery
摘要: Purpose This updated provisional clinical opinion presents a revised based on American Society of Clinical Oncology panel consensus in the context an evolving database. Context Despite 2010 recommendation, there is still evidence suboptimal hepatitis B virus (HBV) screening among patients at high risk for HBV infection or reactivation after chemotherapy. introduces risk-adaptive strategy to identify and treat with reduce their reactivation. Provisional Opinion Medical providers should screen by testing before starting anti-CD20 therapy hematopoietic cell transplantation. Providers also factors infection. Screening include both surface antigen (HBsAg) core antibody (anti-HBc), because can occur who are HBsAg positive/anti-HBc positive ...
sci-hub.se 参考文章(31)
Christopher McNamara, John Davies, Martin Dyer, Peter Hoskin, Tim Illidge, Matthew Lyttelton, Robert Marcus, Silvia Montoto, Alan Ramsay, Wai Lup Wong, Kint Ardeshna, None, Guidelines on the investigation and management of follicular lymphoma. British Journal of Haematology. ,vol. 156, pp. 446- 467 ,(2012) , 10.1111/J.1365-2141.2011.08969.X
Andrew D. Zelenetz, Leo I. Gordon, William G. Wierda, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis, Nancy Bartlett, John C. Byrd, Myron S. Czuczman, Luis E. Fayad, Richard I. Fisher, Martha J. Glenn, Nancy Lee Harris, Richard T. Hoppe, Steven M. Horwitz, Christopher R. Kelsey, Youn H. Kim, Susan Krivacic, Ann S. LaCasce, Auayporn Nademanee, Pierluigi Porcu, Oliver Press, Rachel Rabinovitch, Nishitha Reddy, Erin Reid, Ayman A. Saad, Lubomir Sokol, Lode J. Swinnen, Christina Tsien, Julie M. Vose, Joachim Yahalom, Nadeem Zafar, Mary Dwyer, Hema Sundar, Non-Hodgkin's lymphomas, version 4.2014 Journal of The National Comprehensive Cancer Network. ,vol. 12, pp. 1282- 1303 ,(2014) , 10.6004/JNCCN.2014.0125
He Huang, Xueying Li, Jun Zhu, Sheng Ye, Hongyu Zhang, Wei Wang, Xiangyuan Wu, Jiewen Peng, Bing Xu, Yingcheng Lin, Yabing Cao, Haoran Li, Suxia Lin, Qing Liu, Tongyu Lin, Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial. JAMA. ,vol. 312, pp. 2521- 2530 ,(2014) , 10.1001/JAMA.2014.15704
Christian Trépo, Henry L Y Chan, Anna Lok, Hepatitis B virus infection The Lancet. ,vol. 384, pp. 2053- 2063 ,(2014) , 10.1016/S0140-6736(14)60220-8
Chiun Hsu, Hsiao-Hui Tsou, Shyh-Jer Lin, Ming-Chung Wang, Ming Yao, Wen-Li Hwang, Woei-Yau Kao, Chang-Fang Chiu, Sheng-Fung Lin, Johnson Lin, Cheng-Shyong Chang, Hwei-Fang Tien, Tsang-Wu Liu, Pei-Jer Chen, Ann-Lii Cheng, , Chemotherapy‐induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study Hepatology. ,vol. 59, pp. 2092- 2100 ,(2014) , 10.1002/HEP.26718
Jessica P Hwang, Michael J Fisch, Anna SF Lok, Hong Zhang, John M Vierling, Maria E Suarez-Almazor, None, Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center BMC Cancer. ,vol. 13, pp. 534- 534 ,(2013) , 10.1186/1471-2407-13-534
Robert P. Perrillo, Robert Gish, Yngve T. Falck-Ytter, American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy Gastroenterology. ,vol. 148, pp. 215- 219 ,(2015) , 10.1053/J.GASTRO.2014.10.038
Barbara Rehermann, Carlo Ferrari, Claudio Pasquinelli, Francis V. Chisari, The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response Nature Medicine. ,vol. 2, pp. 1104- 1108 ,(1996) , 10.1038/NM1096-1104
Jeremy S. Abramson, Raymond T. Chung, Optimal antiviral prophylaxis against hepatitis B reactivation in patients receiving rituximab-based chemotherapy for lymphoma. JAMA. ,vol. 312, pp. 2505- 2507 ,(2014) , 10.1001/JAMA.2014.16095
W Yeo, B Zee, S Zhong, P K S Chan, W-L Wong, W M Ho, K C Lam, P J Johnson, Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. British Journal of Cancer. ,vol. 90, pp. 1306- 1311 ,(2004) , 10.1038/SJ.BJC.6601699